World's Best Scientists 2026 revealed!
Francesco Rodeghiero

Francesco Rodeghiero

D-Index & Metrics

Medicine

D-Index
95
Citations
45601
World Ranking
9896
National Ranking
275

Overview

Francesco Rodeghiero is affiliated with Yamagata University in Japan and has contributed to the field of medicine, with particular focus on hematology and related subfields. Their research encompasses a range of topics including myeloproliferative neoplasms, platelet disorders, eosinophilic syndromes, and antiplatelet therapy.

They have authored publications covering diverse aspects of blood disorders, often examining clinical treatments and disease progression. Notable recent papers include:

  • A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia, 2020, Blood
  • Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial, 2024, American Journal of Hematology
  • The impact of thrombosis on probabilities of death and disease progression in polycythemia vera: a multistate transition analysis of 1,545 patients, 2023, Blood Cancer Journal
  • Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia, 2021, Clinical Pharmacology & Therapeutics
  • Splenectomy: still a life-saving treatment in immune thrombocytopenia, 2025, Haematologica

Their frequent coauthors include Marco Ruggeri, Maria Luigia Randi, Irene Bertozzi, Alessandro M. Vannucchi, and Bianca Rocca, illustrating collaboration within the hematology research community.

Publications by Francesco Rodeghiero have appeared in venues such as Blood, American Journal of Hematology, Blood Cancer Journal, Clinical Pharmacology & Therapeutics, and Haematologica, reflecting a focus on hematological research.

Main fields of study linked to their research include Medicine, with subfields centering on hematology, genetics, rheumatology, cardiology and cardiovascular medicine, as well as molecular biology.

Their core research topics cover:

  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Platelet Disorders and Treatments
  • Eosinophilic Disorders and Syndromes
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Kruppel-like factors research
  • Blood groups and transfusion
  • Renal Diseases and Glomerulopathies

Best Publications

  • Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

    Francesco Rodeghiero;Roberto Stasi;Terry Gernsheimer;Marc Michel

  • International consensus report on the investigation and management of primary immune thrombocytopenia.

    Drew Provan;Roberto Stasi;Adrian C. Newland;Victor S. Blanchette

  • Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

    J Danesh;S Lewington;S G Thompson;Lowe Gdo.

  • Epidemiological Investigation of the Prevalence of von Willebrand's Disease

    Francesco Rodeghiero;Giancarlo Castaman;Enrico Dini

  • Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor

    J E Sadler;U Budde;J C J Eikenboom;E J Favaloro

  • Hydroxyurea for Patients with Essential Thrombocythemia and a High Risk of Thrombosis

    Sergio Cortelazzo;Guido Finazzi;Marco Ruggeri;Oscar Vestri

  • Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups.

    Miguel A. Sanz;Francesco Lo Coco;Guillermo Martı́n;Giuseppe Avvisati

  • Survival and prognosis among 1545 patients with contemporary polycythemia vera: An international study

    A Tefferi;E Rumi;G Finazzi;H Gisslinger

  • Molecular Remission in PML/RARα-Positive Acute Promyelocytic Leukemia by Combined All-trans Retinoic Acid and Idarubicin (AIDA) Therapy

    Franco Mandelli;Daniela Diverio;Giuseppe Avvisati;Anna Luciano

  • Impact, Diagnosis and Treatment of von Willebrand Disease*

    J E Sadler;P M Mannucci;Erik Berntorp;N Bochkov

  • Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)

    Tiziano Barbui;Guido Finazzi;Alessandra Carobbio;Juergen Thiele

  • Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia.

    Sergio Cortelazzo;Piera Viero;Guido Finazzi;Anna D'Emilio

  • A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)

    A Tosetto;F Rodeghiero;G Castaman;A Goodeve

  • Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study

    Tiziano Barbui;Juergen Thiele;Francesco Passamonti;Elisa Rumi

  • Phenotype and genotype of a cohort of families historically diagnosed with Type 1 von Willebrand Disease in the European study, molecular and clinical markers for the diagnosis and management of Type 1 von Willebrand Disease (MCMDM-1VWD)

    Anne C. Goodeve;Jeroen Eikenboom;Giancarlo Castaman;Francesco Rodeghiero

  • Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients.

    Alessandra Carobbio;Juergen Thiele;Francesco Passamonti;Elisa Rumi

  • Prognostic impact of c-KIT mutations in core binding factor leukemias. an Italian retrospective study

    Roberto Cairoli;Alessandro Beghini;Giovanni Grillo;Gianpaolo Nadali

  • Romiplostim or standard of care in patients with immune thrombocytopenia.

    David J. Kuter;Mathias Rummel;Ralph Boccia;B. Gail Macik

  • The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study.

    F Rodeghiero;G Castaman;A Tosetto;J Batlle

  • Acquired von Willebrand syndrome: data from an international registry.

    A. B. Federici;J. H. Rand;P. Bucciarelli;U. Budde

Frequent Co-Authors

Tiziano Barbui
Tiziano Barbui FROM-Fondazione per la Ricerca Ospedale di Bergamo
Alessandro Rambaldi
Alessandro Rambaldi University of Milan
Alessandro M. Vannucchi
Alessandro M. Vannucchi University of Florence
Guido Finazzi
Guido Finazzi Mario Negri Institute for Pharmacological Research
Pier Mannuccio Mannucci
Pier Mannuccio Mannucci Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Giovanni Pizzolo
Giovanni Pizzolo University of Verona
Francesco Passamonti
Francesco Passamonti University of Milan
Ayalew Tefferi
Ayalew Tefferi Mayo Clinic
Wilma Barcellini
Wilma Barcellini Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Ingrid Pabinger
Ingrid Pabinger Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA can be complemented by a variety of related online degrees and flexible career pathways. For Registered Nurses looking to advance skills and move into practitioner roles, the rn to np bridge program offers an accelerated route to become a nurse practitioner. This pathway is ideal for nurses seeking more autonomy and responsibility in patient care.

For those interested in nutrition and wellness, earning a nutritionist online degree opens doors in healthcare, sports, and community settings. These degrees are especially relevant as dietary guidance plays an increasing role in preventive medicine.

Leadership roles in health services are another growing area—an option is pursuing cahme accredited online healthcare administration programs. These provide training for management and policy positions in hospitals, clinics, or public health organizations.

Lastly, if you are a nurse aiming to boost credentials quickly, online rn to bsn programs no clinicals offer a streamlined learning experience without traditional in-person requirements.

Best Scientists Citing Francesco Rodeghiero

Trending Scientists

Recently Published Articles